All News

Pharmacy has provided varied and fruitful careers along many different paths for 10 members of this family (so far). Who knows what new forms of practice the next generation might discover?

In the November 4 Drug Topics’ Special Report (15 hospitals to be evaluated on insulin-pen safety), the headline and summary seemed to imply that the 15 hospitals had been singled out due to their unsafe practices with insulin pens. This is not the case. The hospitals were selected to participate in the ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety. Drug Topics regrets any misunderstanding.

Games insurers play

Insurance carriers just do not cover compounded medications - any compound - for any reason. Why? Because they do not want to.

SGLT2 inhibitors, GLP-1 receptor agonists, inhaled insulin, extended-release treatments, and fixed-dose combination therapies are among the approaches that have emerged to treat the exploding numbers of type 2 diabetes patients.